| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/04/2013 | WO2013049509A1 Assay panel for non-alcoholic steatohepatitis |
| 04/04/2013 | WO2013049455A1 Biodosimetry panels and methods |
| 04/04/2013 | WO2013049444A1 Devices, compositions, and methods for detecting molecules and forces |
| 04/04/2013 | WO2013049409A2 Substrates having nanostructures having biological species immobilized thereon and methods of forming the same and methods of forming nanostructures on surfaces |
| 04/04/2013 | WO2013049362A2 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 04/04/2013 | WO2013049214A1 Cysteine protease cwp84 (cd2728) as a diagnostic marker for clostridium difficile |
| 04/04/2013 | WO2013049093A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | WO2013048553A1 Tube and float systems |
| 04/04/2013 | WO2013048446A1 Devices to detect a substance and methods of producing such a device |
| 04/04/2013 | WO2013048344A1 Urinary metabolomic markers for renal insufficiency |
| 04/04/2013 | WO2013048328A1 Systems and methods for self-referenced detection and imaging of sample arrays |
| 04/04/2013 | WO2013048323A1 System and method to separate cells and/or particles |
| 04/04/2013 | WO2013048318A1 Surface plasmon resonance biosensor system |
| 04/04/2013 | WO2013048227A1 Method and system for detection of natural high intensity sweeteners that contain hydroxyl groups |
| 04/04/2013 | WO2013047910A1 Method for evaluating degree of cancerization |
| 04/04/2013 | WO2013047799A1 Physical/chemical sensor, physical/chemical phenomenon sensing device, and method for manufacturing same |
| 04/04/2013 | WO2013047773A1 Method for inducing orexin neuron |
| 04/04/2013 | WO2013047720A1 Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver |
| 04/04/2013 | WO2013047565A1 Blood component analyzer |
| 04/04/2013 | WO2013047108A1 Test method employing level of soluble vascular endothelial proliferation factor receptor 1 as measure |
| 04/04/2013 | WO2013046995A1 Method for determining color change in oxidation-reduction indicator |
| 04/04/2013 | WO2013046960A1 Nucleic acid construct for use in screening for peptide antibody, and screening method using same |
| 04/04/2013 | WO2013046826A1 Molecular template and method for producing same |
| 04/04/2013 | WO2013046760A1 Stomach cancer inspection method and inspection kit |
| 04/04/2013 | WO2013046722A1 Ion concentration-dependent binding molecule library |
| 04/04/2013 | WO2013046226A2 A novel quantification method for vaccines |
| 04/04/2013 | WO2013046199A1 A novel dt56a compound with novel characteristics |
| 04/04/2013 | WO2013046159A1 Apparatus and method for fluid phase fraction determination using x-rays |
| 04/04/2013 | WO2013046116A1 Apparatus for the processing of single molecules |
| 04/04/2013 | WO2013046005A1 Method for verifying and improving the quality of a metal alloy during the solidification process and device suited to implement said method |
| 04/04/2013 | WO2013045863A1 Detection of e.coli strains of serotype 0104 |
| 04/04/2013 | WO2013045854A1 Fluorogenic peptidase substrate |
| 04/04/2013 | WO2013045843A1 Method for obtaining a value of a score for diagnosing the stage of evolution of human hepatic fibrosis |
| 04/04/2013 | WO2013045737A1 Immunogenic gluten peptides and uses thereof |
| 04/04/2013 | WO2013045672A1 A method for predicting the responsiveness a patient to a treatment with an il-6 antagonist |
| 04/04/2013 | WO2013045646A1 Use of transition-metal oxide nanoparticles as sensitive materials in chemical sensors for detecting or assaying vapors of target molecules |
| 04/04/2013 | WO2013045591A2 Method and kit for the in vitro diagnosis of breast cancer |
| 04/04/2013 | WO2013045570A1 Sflt1 in subjects during or immediately after physical exercise |
| 04/04/2013 | WO2013045539A1 Marker in diagnosing prostate cancer (pc) |
| 04/04/2013 | WO2013045500A1 Method for determining a predictive function for discriminating patients according to their disease activity status |
| 04/04/2013 | WO2013045443A1 Measurement of lactic acid in biological fluids |
| 04/04/2013 | WO2013045112A1 Particular uses of cd24 inhibitors |
| 04/04/2013 | WO2013045033A1 Method of determining the status of cells |
| 04/04/2013 | WO2013044607A1 System for evaluating anti-aging effect of autologous adipose-derived stem cells |
| 04/04/2013 | WO2013044575A1 Elisa kit for detecting polypeptide marker antigen |
| 04/04/2013 | WO2013044420A1 Centrifugal rotary disk |
| 04/04/2013 | WO2013044391A1 Assay for inhibitors of cip/kip protein degradation |
| 04/04/2013 | WO2013023144A3 Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease |
| 04/04/2013 | WO2013023015A3 Targets for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes |
| 04/04/2013 | WO2013022715A8 Rbap48 transgenic mice for drug discovery in age-related memory decline |
| 04/04/2013 | WO2013020933A3 Device and method for producing foods |
| 04/04/2013 | WO2013014287A3 Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use |
| 04/04/2013 | WO2013014286A3 Means and methods for diagnosing and monitoring heart failure in a subject |
| 04/04/2013 | WO2013011294A3 Diagnosis of alzheimer's disease |
| 04/04/2013 | WO2013009927A3 Droplet actuators and techniques for droplet-based assays |
| 04/04/2013 | WO2013003583A3 Somatic mutations in atrx in brain cancer |
| 04/04/2013 | WO2012174569A3 New markers for early diagnosis of ovarian cancer, monitoring during therapy, and new therapy options during and after chematherapy |
| 04/04/2013 | WO2012174014A3 Low density microarrays for vaccine related protein quantification, potency determination and efficacy evaluation |
| 04/04/2013 | WO2012173343A3 Nanopositioning substrate preparation apparatus and preparation method using dip pen nanolithography with single or multiple tips using atomic force microscope (afm) |
| 04/04/2013 | WO2012170740A3 Biomarker of asbestos exposure and mesothelioma |
| 04/04/2013 | WO2012170614A3 Dna methylation markers in non-small cell lung cancer and methods of using the same |
| 04/04/2013 | WO2012168184A3 Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles |
| 04/04/2013 | WO2012165926A3 Marker for diagnosing liver cancer containing anti-atic autoantibody, and composition for diagnosing liver cancer containing antigen thereof |
| 04/04/2013 | WO2012162514A3 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
| 04/04/2013 | WO2012142623A3 Antigen detection system and methods of use |
| 04/04/2013 | WO2012129395A3 Diagnosis and treatment of prostate cancer |
| 04/04/2013 | WO2012112156A3 Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof |
| 04/04/2013 | WO2011158016A3 Assay |
| 04/04/2013 | WO2011140464A9 MASS SPECTROMETRY ASSAY FOR elF4E AND elF4E REGULON ACTIVITY |
| 04/04/2013 | US20130086703 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 04/04/2013 | US20130085768 Modular microprocessor-based appliance system |
| 04/04/2013 | US20130085169 Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
| 04/04/2013 | US20130085076 Borrelia burgdorferi bacterial antigen diagnosic test using polymeric bait containing capture particles |
| 04/04/2013 | US20130085075 Diagnostic methods for liver disorders |
| 04/04/2013 | US20130085074 Antibody Categorization Based on Binding Characteristics |
| 04/04/2013 | US20130084651 Test instrument for measuring analyte in sample, and method for measuring analyte using same |
| 04/04/2013 | US20130084650 Molecular markers for urinary tract infections |
| 04/04/2013 | US20130084596 Methods of identifying lead compounds that modulate toxicity of neurotoxic polypeptides |
| 04/04/2013 | US20130084587 Levels of cytokeratins in blood and body fluids as biomarkers for cancer screening, diagnosis and treatment monitoring |
| 04/04/2013 | US20130084586 Rapid, specific and sensitive immunoassays for the detection of highly variable gram negative bacterial antigens |
| 04/04/2013 | US20130084585 Immunoassay for chromogranin a, antibodies and kit |
| 04/04/2013 | US20130084584 Method to detect tissue degradation leading to inflammation |
| 04/04/2013 | US20130084583 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 04/04/2013 | US20130084582 Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells |
| 04/04/2013 | US20130084581 Method of Identifying Transmembrane Protein-Interacting Compounds |
| 04/04/2013 | US20130084580 Chromatographic kit and chromatography method |
| 04/04/2013 | US20130084579 Drug susceptibility using rare cell detection system |
| 04/04/2013 | US20130084575 Method and device for replicating a cell colony in culture for early analysis |
| 04/04/2013 | US20130084573 Cancer Diagnosis by Measuring Polyisoprenylated Methylated Protein Methyl Esterase Activity |
| 04/04/2013 | US20130084569 Nanomotors and motion-based detection of biomolecular interactions |
| 04/04/2013 | US20130084370 Viscosity-controlled processing of liquid food |
| 04/04/2013 | US20130084301 Cluster of Neutralizing Antibodies to Hepatitis C Virus |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084298 Novel anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof |
| 04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | US20130084283 Oligomer-specific amyloid beta epitope and antibodies |
| 04/04/2013 | US20130084276 Biomarkers of cardiovascular disease including lrg |
| 04/04/2013 | US20130084270 Stem cells from adipose tissue, and differentiated cells from said cells |
| 04/04/2013 | US20130084243 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |